The Business Standard's Smart Investor (SI) reports focus on in-depth analysis and timely news concerning strategic investment trends, business deals, and financial manoeuvres within the corporate world.
The Business Standard's Smart Investor (SI) reports focus on in-depth analysis and timely news concerning strategic investment trends, business deals, and financial manoeuvres within the corporate world.
Financials were among the top losers along with Sun Pharma and index heavyweight Reliance Industries
The order is for 2D Seismic Data Acquisition in parts of Assam & Arunachal Pradesh valued around Rs 102.42 crore.
The govt has directed fertiliser companies to print the MRP and available subsidy on each bag of P&K fertilizers
Investors are keenly awaiting the outcome of the two-day US Federal Reserve policy meet which began yesterday
The stock dipped 13% to Rs 562 on the National Stock Exchange in intra-day trade on back of heavy volumes.
The board had declared an interim dividend of Rs 50 per equity share of Rs 10 each (i.e. 500 %), for FY16.
The stock rallied 6% to Rs 191 after the company declared interim dividend of 150% or Rs 3 per share for the current fiscal.
The stock surged 10% to Rs 3,338 on the National Stock Exchange
Lupin was the top Sensex loser down 9% amid observations by USFDA at Goa unit
Lupin, Divis Lab, Aurobindo, Dishman Pharma, Jubilant Life, Natco Pharma and Pfizer were down 3%-7% on BSE.
ITC, Infosys and ICICI Bank collectively contributed 370 points of the Sensex's 777 points rise, the BSE data showed.
Nifty Auto index was up 4% as compared to 3% gain in the Nifty 50 index at 02:51 PM
The company has received final approval from the USFDA for Glyburide and Metformin Hcl tablets USP
Vedanta has emerged as the successful bidder for the Baghmara Gold block in the State of Chhattisgarh
Axis Bank has acquired 5% stake in Max Life Insurance raising its total stake to 5.99%
Shareholders via a postal ballot approved bonus share issue in the ratio of 1:1
In February, the stock had underperformed the market, fallen 21% as compared to 7.5% decline in Nifty 50 index.
The stock was trading higher by 3% to Rs 1,115 on the BSE.
The stock was up 8% at Rs 319, rallied 19% from its 52-week low of Rs 268 touched on Monday in intra-day trade.
The stock was up 2% to Rs 971 on the BSE in early morning trade.